DOCSLIB.ORG

Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin James L

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin James L Dose Response of Arginine Vasopressin to the CCK-B Agonist Pentagastrin James L. Abelson, M.D., Ph.D., Jean-Michel Le Mellédo, M.D., and Daniel G. Bichet, M.D., FRCPC Cholecystokinin (CCK) is a peptide neurotransmitter that agonist. However, this may have been due to a greater modulates hypothalamic-pituitary-adrenal (HPA) axis percentage of subjects releasing AVP in the higher dose activity and may be involved in fear or anxiety states. groups, rather than a direct effect of dose on magnitude of Arginine vasopressin (AVP) also modulates HPA axis response. AVP and ACTH responses were correlated, but activity and may play a role in fear conditioning. Few AVP response alone could not account for the magnitude of human studies have examined interactions between CCK the ACTH response. AVP release was significantly and AVP systems. To explore relationships between CCK-B correlated with anxiety symptom responses. These findings receptor activation, the HPA axis response, and AVP suggest a possible role for the CCK-B receptor in AVP release, a dose-response study using the CCK-B receptor release, which may be at least partially separate from its role agonist pentagastrin was conducted. Adrenocorticotropin in modulation of the HPA axis. Further work is needed to (ACTH) and cortisol results have been previously reported determine whether these are physiologically meaningful and AVP data is presented here. Thirty-five healthy interactions and to determine their functional implications. subjects were randomly assigned to receive placebo, or 0.2, [Neuropsychopharmacology 24:161–169, 2001] 0.4, 0.6, or 0.8 ␮g/kg doses of pentagastrin. AVP release © 2000 American College of Neuropsychopharmacology. appeared to increase with increasing doses of the CCK-B Published by Elsevier Science Inc. KEY WORDS: Cholecystokinin; Vasopressin; Pentagastrin; functioning as a neuromodulator of the hypothalamic- Anxiety; Panic disorder pituitary-adrenal (HPA) axis (Abelson and Liberzon 1999). CCK-B agonists, such as pentagastrin, activate the Cholecystokinin (CCK) is a peptide neurotransmitter that HPA axis in humans, stimulating release of adrenocorti- is widely distributed in brain areas involved with cogni- cotropin (ACTH) and cortisol (Abelson and Liberzon tive or emotional aspects of behavior, such as prefrontal 1999; Abelson et al. 1994; de Montigny 1989; Degli Uberti cortex, cingulate, hippocampus, amygdala, and the locus et al. 1983; Späth-Schwalbe et al. 1988). coeruleus (Lindefors et al. 1993; Saito et al. 1980). Some Levels of CCK and corticotropin-releasing hormone evidence suggests it may modulate stress responsiveness, (CRH) were found to be correlated in human cere- brospinal fluid, suggesting that central regulation of these two neuropeptides may be linked in humans; and From the University of Michigan Department of Psychiatry, Anx- this linkage may be tighter under conditions of stress iety Disorders Program, Ann Arbor, MI (JLA); Department of Psy- (Geracioti et al. 1999). Animal work also demonstrates chiatry, University of Alberta, Edmonton, Alberta, Canada (J- substantial interaction between CCK and the HPA axis. MLM); and University of Montreal, Hôpital Sacré-Coeur, Montreal, Quebec, Canada (DGB). The axis is directly sensitive to CCK activation (Kami- Address correspondence to: James L. Abelson, M.D., Ph.D., Rm laris et al. 1992; Matsumura et al. 1983; Mezey et al. C435, Med Inn Bldg/0840, 1500 E. Medical Center Drive, Ann 1986; Reisine and Jensen 1986); and CCK peptide is co- Arbor, MI 48109–0840. Received 24 January 2000; revised 4 May 2000; accepted 19 July localized with other HPA axis secretagogues (Kiss et al. 2000. 1984; Larsson and Rehfeld 1981; Mezey et al. 1986; Mill- NEUROPSYCHOPHARMACOLOGY 2001–VOL. 24, NO. 2 © 2000 American College of Neuropsychopharmacology Published by Elsevier Science Inc. 0893-133X/01/$–see front matter 655 Avenue of the Americas, New York, NY 10010 PII S0893-133X(00)00182-2 162 J.L. Abelson et al. NEUROPSYCHOPHARMACOLOGY 2001–VOL. 24, NO. 2 ington et al. 1992; Rehfeld 1978; Rehfeld and Larsson links, and potential relevance to mood and anxiety dis- 1981; Rehfeld et al. 1987; Vanderhaeghen et al. 1985). orders, further exploration of interactions between Central CCK systems are stress and glucocorticoid sen- CCK, AVP, and the HPA axis are warranted. We have sitive (Mezey et al. 1986; Siegel et al. 1987); and periph- recently demonstrated in human subjects that the CCK- eral CCK can regulate activity in central components of B agonist pentagastrin releases ACTH and cortisol in a the HPA axis (Chen et al. 1993). dose-dependent fashion (Abelson and Liberzon 1999). Though CCK-HPA axis interactions are well estab- We have also shown that another CCK-B agonist (CCK- lished, the mechanisms by which they interact remain 4) can release AVP in humans (Le Mellédo et al. in uncertain. Central regulation of the HPA axis is exerted press). To determine whether pentagastrin stimulates primarily through corticotropin-releasing hormone AVP release in a dose-dependent fashion and whether (CRH), arginine vasopressin (AVP), and negative gluco- AVP participates in the ACTH response to pentagas- corticoid inhibition (Aguilera 1994). Animal work sug- trin, we have now also examined plasma AVP re- gests that both CRH (Biró et al. 1993; Kamilaris et al. 1992) sponses following varying doses of intravenous penta- and AVP (Bondy et al. 1989; DeBold et al. 1984; Mezey et gastrin. al. 1986; Verbalis et al. 1987) could mediate CCK effects on the HPA axis. However, due to substantial cross spe- cies variation in CCK function (Hinks et al. 1995; Wood- METHODS ruff et al. 1991), human studies will be needed to clarify Subjects these mechanisms in humans. CCK-induced release of ACTH differs from that seen with human CRH in its ra- As previously described (Abelson and Liberzon 1999), pidity, brevity, and relative resistance to cortisol feedback subjects were 19 female and 16 male healthy adults, inhibition (Abelson and Liberzon 1999; DeCherney et al. with a mean age of 26.3 Ϯ 7.7 years (range, 18–45 1985; Hermus et al. 1984; Schürmeyer et al. 1984), raising years). They were recruited through newspaper adver- questions about the role of CRH as mediator of the hu- tising, screened using the Structured Clinical Interview man HPA response to CCK agonism. A very rapid and for DSM-IV (SCID) to insure the absence of psychiatric robust release of AVP is seen in humans after CCK ago- disorders, and paid $100 for their participation. An ab- nist injection (Le Mellédo et al. 1997; Miaskiewicz et al. breviated Family Informant Schedule and Criteria in- 1989), supporting its potential role as mediator of CCK terview (Mannuzza et al. 1985) was used to exclude activation of the HPA axis. No human studies to date those with affective or anxiety disorders in first degree have simultaneously examined both ACTH and AVP relatives. Subjects had no recent (three months) serious responses to CCK receptor agonists. medical illness, no history of alcohol or drug depen- Functional interactions between CCK, AVP, and the dence, and no recent (six months) drug or alcohol HPA axis could be important to our understanding of a abuse. They did not smoke more than 20 cigarettes per number of clinical conditions. The CCK-B receptor is day or drink more than four cans of beer (or the equiva- thought to play a role in anxiety states (Bradwejn and lent) per week in the past 6 months. They were within Koszycki 1994; Harro et al. 1993) and CCK-B agonists Ϫ10% and ϩ25% of ideal body weight, had a negative reliably elicit panic attacks in the laboratory (Abelson urine drug screen, and had normal screening laboratory and Nesse 1994; Bradwejn et al. 1991; de Montigny tests (blood counts, electrolytes, glucose, liver and renal 1989). Panic patients show subtle abnormalities in HPA functions). Female subjects were pre-menopausal, were axis activity (Abelson and Curtis 1996), similar to those not taking birth control pills, and were studied within seen in patients with depression (Linkowski et al. 1985). the first 10 days after the onset of menstruation (to pre- Recent work suggests that HPA axis dysregulation in clude the possibility of pregnancy and control for ef- depression may be associated with a shift towards in- fects of menstrual cycle on the HPA axis). All subjects creased vasopressinergic control of the axis (Dinan et al. provided written informed consent. 1999; Holsboer and Barden 1996). Abnormalities in AVP levels or receptor activity have been detected in Procedures depression (Purba et al. 1996; van Londen et al. 1997) and obsessive-compulsive disorder (Altemus et al. Subjects were assigned (by constrained random assign- 1992), but have not yet been studied in other anxiety ment to give approximately equal age and gender dis- disorders. Evidence that AVP may play a role in condi- tributions in each group) to a placebo group or one of tioned fear (Stoehr et al. 1993), avoidance learning (In- four dose groups (0.2, 0.4, 0.6, and 0.8 ␮g/kg). The se- sel et al. 1999), and novelty sensitivity (Ehrenreich et al. lection of doses was based on the study’s primary focus 1996) suggests a possible relevance to phobic behavior on ACTH and cortisol (Abelson and Liberzon 1999). and panic. An AVP antagonist has shown some anxi- Subjects and nursing staff were blind to group assign- olytic activity in an animal model (Liebsch et al. 1996). ment. The experiment was conducted in a General Clin- Given the pharmacological and neuroanatomical ical Research Center (GCRC), where subjects were ad- NEUROPSYCHOPHARMACOLOGY 2001–VOL. 24, NO. 2 Vasopressin Response to Pentagastrin 163 mitted at 1:00 p.m. An intravenous catheter was added to plasma from patients with central diabetes in- inserted into a forearm or antecubital vein and kept sipidus to calculate recoveries (done with every assay). open with a normal saline drip.
Load more

Recommended publications
  • Strategies to Increase ß-Cell Mass Expansion
    This electronic thesis or dissertation has been downloaded from the King’s Research Portal at https://kclpure.kcl.ac.uk/portal/ Strategies to increase -cell mass expansion Drynda, Robert Lech Awarding institution: King's College London The copyright of this thesis rests with the author and no quotation from it or information derived from it may be published without proper acknowledgement. END USER LICENCE AGREEMENT Unless another licence is stated on the immediately following page this work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ You are free to copy, distribute and transmit the work Under the following conditions: Attribution: You must attribute the work in the manner specified by the author (but not in any way that suggests that they endorse you or your use of the work). Non Commercial: You may not use this work for commercial purposes. No Derivative Works - You may not alter, transform, or build upon this work. Any of these conditions can be waived if you receive permission from the author. Your fair dealings and other rights are in no way affected by the above. Take down policy If you believe that this document breaches copyright please contact [email protected] providing details, and we will remove access to the work immediately and investigate your claim. Download date: 02. Oct. 2021 Strategies to increase β-cell mass expansion A thesis submitted by Robert Drynda For the degree of Doctor of Philosophy from King’s College London Diabetes Research Group Division of Diabetes & Nutritional Sciences Faculty of Life Sciences & Medicine King’s College London 2017 Table of contents Table of contents .................................................................................................
    [Show full text]
  • The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands
    The Activation of the Glucagon-Like Peptide-1 (GLP-1) Receptor by Peptide and Non-Peptide Ligands Clare Louise Wishart Submitted in accordance with the requirements for the degree of Doctor of Philosophy of Science University of Leeds School of Biomedical Sciences Faculty of Biological Sciences September 2013 I Intellectual Property and Publication Statements The candidate confirms that the work submitted is her own and that appropriate credit has been given where reference has been made to the work of others. This copy has been supplied on the understanding that it is copyright material and that no quotation from the thesis may be published without proper acknowledgement. The right of Clare Louise Wishart to be identified as Author of this work has been asserted by her in accordance with the Copyright, Designs and Patents Act 1988. © 2013 The University of Leeds and Clare Louise Wishart. II Acknowledgments Firstly I would like to offer my sincerest thanks and gratitude to my supervisor, Dr. Dan Donnelly, who has been nothing but encouraging and engaging from day one. I have thoroughly enjoyed every moment of working alongside him and learning from his guidance and wisdom. My thanks go to my academic assessor Professor Paul Milner whom I have known for several years, and during my time at the University of Leeds he has offered me invaluable advice and inspiration. Additionally I would like to thank my academic project advisor Dr. Michael Harrison for his friendship, help and advice. I would like to thank Dr. Rosalind Mann and Dr. Elsayed Nasr for welcoming me into the lab as a new PhD student and sharing their experimental techniques with me, these techniques have helped me no end in my time as a research student.
    [Show full text]
  • Neuropeptides As Attractants of Immune Cells in the Brain and Their Distinct Signaling
    Advances in Neuroimmune Biology 1 (2011) 53–62 53 DOI 10.3233/NIB-2011-005 IOS Press Neuropeptides as Attractants of Immune Cells in the Brain and their Distinct Signaling Mami Noda∗, Masataka Ifuku, Yuko Okuno, Kaoru Beppu, Yuki Mori and Satoko Naoe Laboratory of Pathophysiology, Graduate School of Pharmaceutical Sciences, Kyushu University, Fukuoka, Japan Abstract. Microglia, the immune cells of the central nervous system (CNS), are busy and vigilant housekeepers in the adult brain. The main candidate as a chemoattractant for microglia at damaged site is adenosine triphosphate (ATP). However, many other substances can induce immediate change of microglia. Some neuropeptides such as angiotensin II, bradykinin (BK), endothelin, galanin (GAL), and neurotensin are also chemoattractants for microglia. Among them, BK increased microglial migration via B1 receptor with different mechanism from that of ATP. BK-induced migration was controlled by a Gi/o protein-independent pathway, while ATP-induced migration was via a Gi/o protein-dependent and also a mitogen-activated protein kinase (MAPK) / extracellular signal-regulated kinase (ERK)-dependent pathway. On the other hand, GAL is reported to have a similar signal cascade as that of BK, though only part of the signaling was similar to that of BK-induced migration. For example, BK activates reverse-mode Na+/Ca2+ exchange allowing extracllular Ca2+ influx, while GAL induces intracellular Ca2+ mobilization via increasing inositol-1,4,5-trisphosphate. In addition, GAL activates MAPK/ERK-dependent signaling but BK did not. These results suggest that chemoattractants for immune cells in the brain including ATP and each peptide may have distinct role under both physiological and pathophysiological conditions.
    [Show full text]
  • Cionin, a Vertebrate Cholecystokinin/Gastrin
    www.nature.com/scientificreports OPEN Cionin, a vertebrate cholecystokinin/gastrin homolog, induces ovulation in the ascidian Ciona intestinalis type A Tomohiro Osugi, Natsuko Miyasaka, Akira Shiraishi, Shin Matsubara & Honoo Satake* Cionin is a homolog of vertebrate cholecystokinin/gastrin that has been identifed in the ascidian Ciona intestinalis type A. The phylogenetic position of ascidians as the closest living relatives of vertebrates suggests that cionin can provide clues to the evolution of endocrine/neuroendocrine systems throughout chordates. Here, we show the biological role of cionin in the regulation of ovulation. In situ hybridization demonstrated that the mRNA of the cionin receptor, Cior2, was expressed specifcally in the inner follicular cells of pre-ovulatory follicles in the Ciona ovary. Cionin was found to signifcantly stimulate ovulation after 24-h incubation. Transcriptome and subsequent Real-time PCR analyses confrmed that the expression levels of receptor tyrosine kinase (RTK) signaling genes and a matrix metalloproteinase (MMP) gene were signifcantly elevated in the cionin-treated follicles. Of particular interest is that an RTK inhibitor and MMP inhibitor markedly suppressed the stimulatory efect of cionin on ovulation. Furthermore, inhibition of RTK signaling reduced the MMP gene expression in the cionin-treated follicles. These results provide evidence that cionin induces ovulation by stimulating MMP gene expression via the RTK signaling pathway. This is the frst report on the endogenous roles of cionin and the induction of ovulation by cholecystokinin/gastrin family peptides in an organism. Ascidians are the closest living relatives of vertebrates in the Chordata superphylum, and thus they provide important insights into the evolution of peptidergic systems in chordates.
    [Show full text]
  • Reorganization of Neural Peptidergic Eminence After Hypophysectomy
    The Journal of Neuroscience, October 1994, 14(10): 59966012 Reorganization of Neural Peptidergic Systems Median Eminence after Hypophysectomy Marcel0 J. Villar, Bjiirn Meister, and Tomas Hiikfelt Department of Neuroscience, The Berzelius Laboratory, Karolinska Institutet, Stockholm, 171 77 Sweden Earlier studies have shown the formation of a novel neural crease to a final stage of a few, strongly immunoreactive lobe after hypophysectomy, an experimental manipulation fibers in the external layer at longer survival times. Vaso- that causes transection of neurohypophyseal nerve fibers active intestinal polypeptide (VIP)- and peptide histidine- and removal of pituitary hormones. The mechanisms that isoleucine (PHI)-IR fibers in hypophysectomized animals had underly this regenerative process are poorly understood. already contacted portal vessels 5 d after hypophysectomy, The localization and number of peptide-immunoreactive and from then on progressively increased in numbers. Fi- (-IR) fibers in the median eminence were studied in normal nally, most of the peptide fibers described above formed rats and in rats at different times of survival after hypophy- dense innervation patterns around the large blood vessels sectomy using indirect immunofluorescence histochemistry. along the lateral borders of the median eminence. The number of vasopressin (VP)-IR fibers increased in the The present results show that hypophysectomy induces external layer of the median eminence in 5 d hypophysec- a wide variety of changes in hypothalamic neurosecretory tomized rats. Oxytocin (OXY)-IR fibers decreased in the in- fibers. Not only is the expression of several peptides in these ternal layer and progressively extended into the external fibers modified following different survival times, but a re- layer.
    [Show full text]
  • Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells
    Expression and localization of gastrin messenger RNA and peptide in spermatogenic cells. M Schalling, … , T Hökfelt, J F Rehfeld J Clin Invest. 1990;86(2):660-669. https://doi.org/10.1172/JCI114758. Research Article In previous studies we have shown that the gene encoding cholecystokinin (CCK) is expressed in spermatogenic cells of several mammalian species. In the present study we show that a gene homologous to the CCK-related hormone, gastrin, is expressed in the human testis. The mRNA hybridizing to a human gastrin cDNA probe in the human testis was of the same size (0.7 kb) as gastrin mRNA in the human antrum. By in situ hybridization the gastrinlike mRNA was localized to seminiferous tubules. Immunocytochemical staining of human testis revealed gastrinlike peptides in the seminiferous tubules primarily at a position corresponding to spermatids and spermatozoa. In ejaculated spermatozoa gastrinlike immunoreactivity was localized to the acrosome. Acrosomal localization could also be shown in spermatids with electron microscopy. Extracts of the human testis contained significant amounts of progastrin, but no bioactive amidated gastrins. In contrast, ejaculated sperm contained mature carboxyamidated gastrin 34 and gastrin 17. The concentration of gastrin in ejaculated human spermatozoa varied considerably between individuals. We suggest that amidated gastrin (in humans) and CCK (in other mammals) are released during the acrosome reaction and that they may be important for fertilization. Find the latest version: https://jci.me/114758/pdf Expression and Localization of Gastrin Messenger RNA and Peptide in Spermatogenic Cells Martin Schalling,* Hhkan Persson,t Markku Pelto-Huikko,*9 Lars Odum,1I Peter Ekman,I Christer Gottlieb,** Tomas Hokfelt,* and Jens F.
    [Show full text]
  • Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J
    The Open Nutrition Journal, 2009, 3, 5-7 5 Open Access Low Ambient Temperature Lowers Cholecystokinin and Leptin Plasma Concentrations in Adult Men Monika Pizon, Przemyslaw J. Tomasik*, Krystyna Sztefko and Zdzislaw Szafran Department of Clinical Biochemistry, University Children`s Hospital, Krakow, Poland Abstract: Background: It is known that the low ambient temperature causes a considerable increase of appetite. The mechanisms underlying the changes of the amounts of the ingested food in relation to the environmental temperature has not been elucidated. The aim of this study was to investigate the effect of the short exposure to low ambient temperature on the plasma concentration of leptin and cholecystokinin. Methods: Sixteen healthy men, mean age 24.6 ± 3.5 years, BMI 22.3 ± 2.3 kg/m2, participated in the study. The concen- trations of plasma CCK and leptin were determined twice – before and after the 30 min. exposure to + 4 °C by using RIA kits. Results: The mean value of CCK concentration before the exposure to low ambient temperature was 1.1 pmol/l, and after the exposure 0.6 pmol/l (p<0.0005 in the paired t-test). The mean values of leptin before exposure (4.7 ± 1.54 μg/l) were also significantly lower than after the exposure (6.4 ± 1.7 μg/l; p<0.0005 in the paired t-test). However no significant cor- relation was found between CCK and leptin concentrations, both before and after exposure to low temperature. Conclusions: It has been known that a fall in the concentration of CCK elicits hunger and causes an increase in feeding activity.
    [Show full text]
  • Non Conventional Synthetic Strategies of Stapled Peptides: Modulation of Secondary Structures to Optimise Biological Recognition
    PhD THESIS OF THE UNIVERSITY OF CERGY-PONTOISE CO-TUTORED WITH THE UNIVERSITY OF FLORENCE Non conventional synthetic strategies of stapled peptides: modulation of secondary structures to optimise biological recognition presented by : Chiara TESTA PhD discussed on March 26th 2012, Composition of the evaluation committee: Pr. Solange LAVIELLE Rapporteur Pr. Luis MORODER Rapporteur Pr. Anna Maria PAPINI Directrice de thèse Pr. Nadège GERMAIN Directrice de thèse Pr. Paolo ROVERO Directeur de thèse Pr. Michael CHOREV Examinateur Pr. Jacques AUGE Examinateur Pr Andrea GOTI Examinateur Chiara Testa, PhD Thesis Table of contents INTRODUCTION .................................................................................................................. 1 1 Difficult peptide synthesis optimized by microwave-assisted approach: a case study of PTHrP(1–34)NH2 ......................................................................................... 18 1.1 The Parathyroid hormone (PTH) and the Parathyroid hormone-related protein (PTHrP) .................................................................................... 18 1.2 Microwave assisted peptide synthesis .................................................. 20 1.2.1 Thermal effects ..................................................................................... 21 1.2.2 Specific non-thermal effects ................................................................. 22 1.2.3 Modes .................................................................................................... 22 1.3 Synthetic
    [Show full text]
  • Effect of Early Vasopressin Vs Norepinephrine On
    Protocol Number: CRO1888 VANISH Vasopressin vs Noradrenaline as Initial therapy in Septic Shock PROTOCOL NUMBER: CRO1888 EudraCT NUMBER: 2011-005363-24 SPONSOR: Imperial College London FUNDER: National Institute for Health Research DEVELOPMENT PHASE: PHASE IV STUDY COORDINATION CENTRE: Imperial Clinical Trials Unit PROTOCOL Version & Date: Version 2.1, 02.08.2013 Property of: Dr Anthony Gordon May not be used, divulged or published without the consent of: Dr Anthony Gordon Confidential Final Version2.1, 02.08.2013 Page 1 of 31 Downloaded From: https://jamanetwork.com/ on 09/29/2021 Protocol Number: CRO1888 Study Management Group Chief Investigator: Dr Anthony Gordon Co-investigators: Dr Stephen Brett Prof Gavin Perkins Prof Deborah Ashby Statistician: Dr Alexina Mason Trial Management: Ms Neeraja Thirunavukkarasu Study Coordination Centre For general queries, supply of trial documentation, and collection of data, please contact: Study Coordinator: Ms Neeraja Thirunavukkarasu Address: ICU – 11N, Charing Cross Hospital, Fulham Palace Road London W6 8RF E-mail: [email protected] Clinical Queries Clinical queries should be directed to Ms Neeraja Thirunavukkarasu who will direct the query to the appropriate person Sponsor Imperial College London is the main research Sponsor for this study. For further information regarding the sponsorship conditions, please contact the Head of Regulatory Compliance at: Joint Research Compliance Office 510, Lab block, 5th Floor Charing Cross Hospital Fulham Palace Road London W6 8RF Tel: 0203 311 0213 Fax: 0203 311 0203 Funder National Institute for Health Research – Research for Patient Benefit and Clinician Scientist award schemes This protocol describes the VANISH study and provides information about procedures for entering participants.
    [Show full text]
  • Making Sense of the Sensory Regulation of Hunger Neurons
    Insights & Perspectives Making sense of the sensory regulation Think again of hunger neurons Yiming Chen and Zachary A. Knight* AgRP and POMC neurons are two key cell types that regulate feeding in such as leptin, and increases the level of response to hormones and nutrients. Recently, it was discovered that these hormones that promote feeding, such as neurons are also rapidly modulated by the mere sight and smell of food. This ghrelin. This hormonal switch activates rapid sensory regulation ‘‘resets’’ the activity of AgRP and POMC neurons AgRP neurons and inhibits POMC neu- before a single bite of food has been consumed. This surprising and rons, creating a “hunger drive” that counterintuitive discovery challenges longstanding assumptions about the motivates animals to find and consume food, and that persists until food intake function and regulation of these cells. Here we review these recent findings and replenishes the body of nutrients. In this discuss their implications for our understanding of feeding behavior. We way, a simple negative feedback loop is propose several alternative hypotheses for how these new observations might thought to explain the remarkable be integrated into a revised model of the feeding circuit, and also highlight some coordination of feeding behavior with of the key questions that remain to be answered. physiologic need. While this homeostatic model is Keywords: widely accepted, one key piece of data has been missing: information about anticipatory; arcuate nucleus; feeding; homeostasis; hunger; hypothalamus; . the activity dynamics of these neurons neural circuit in vivo. In the past year, this gap has Introduction consumption [3–6]. POMC neurons, in been closed, as three groups have contrast, are activated by energy surfeit, reported measurements of AgRP and The body weight of most animals is and their activity promotes fasting and POMC neuron dynamics in awake, remarkably stable over time, suggesting weight loss [3, 7].
    [Show full text]
  • Vasopressin Versus Norepinephrine in Septic Shock: a Propensity Score Matched Efficiency Retrospective Cohort Study in the VASST Coordinating Center Hospital James A
    Russell et al. Journal of Intensive Care (2018) 6:73 https://doi.org/10.1186/s40560-018-0344-2 RESEARCH Open Access Vasopressin versus norepinephrine in septic shock: a propensity score matched efficiency retrospective cohort study in the VASST coordinating center hospital James A. Russell1,2*, Hugh Wellman3 and Keith R. Walley1,2 Abstract Purpose: It is not clear whether vasopressin versus norepinephrine changed mortality in clinical practice in the Vasopressin and Septic Shock Trial (VASST) coordinating center hospital after VASST was published. We tested the hypothesis that vasopressin changed mortality compared to norepinephrine using propensity matching of vasopressin to norepinephrine-treated patients in the VASST coordinating center hospital before (SPH1) and after (SPH2) VASST was published. Methods: Vasopressin-treated patients were propensity score matched to norepinephrine-treated patients based on age, APACHE II, respiratory, renal, and hematologic dysfunction, mechanical ventilation status, medical/surgical status, infection site, and norepinephrine dose. The propensity score estimated the probability that a patient would have received vasopressin given baseline characteristics. For sensitivity analysis, we then excluded patients who had underlying severe congestive heart failure. The primary outcome was 28-day mortality. Results: Vasopressin- and norepinephrine-treated patients were similar after matching in SPH1 (pre-VASST); vasopressin-treated patients (n = 158) had a significantly higher mortality than norepinephrine-treated patients (n = 158) (60.8 vs. 46.2%, p = 0.009). In SPH2 after matching, the 28-day mortality rates were not significantly different; 31.2% and 26.9% in the vasopressin (n = 93) and norepinephrine (n = 93) groups, respectively (p = 0.518). The day 1 vasopressin dose in SPH1 vs.
    [Show full text]
  • The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies
    Nanomaterials 2014, 4, 726-740; doi:10.3390/nano4030726 OPEN ACCESS nanomaterials ISSN 2079-4991 www.mdpi.com/journal/nanomaterials Article The Use of the Calcitonin Minimal Recognition Module for the Design of DOPA-Containing Fibrillar Assemblies Galit Fichman 1,†, Tom Guterman 1,†, Lihi Adler-Abramovich 1 and Ehud Gazit 1,2,* 1 Department of Molecular Microbiology and Biotechnology, George S. Wise Faculty of Life Sciences, Tel Aviv University, Tel Aviv 6997801, Israel; E-Mails: [email protected] (G.F.); [email protected] (T.G.); [email protected] (L.A.-A.) 2 Department of Materials Science and Engineering, Iby and Aladar Fleischman Faculty of Engineering, Tel Aviv University, Tel Aviv 6997801, Israel † These authors are equal contributors to this work. * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +972-3-640-7498; Fax: +972-3-640-7499. Received: 3 June 2014; in revised form: 28 July 2014 / Accepted: 8 August 2014 / Published: 20 August 2014 Abstract: Amyloid deposits are insoluble fibrous protein aggregates, identified in numerous diseases, which self-assemble through molecular recognition. This process is facilitated by short amino acid sequences, identified as minimal modules. Peptides corresponding to these motifs can be used for the formation of amyloid-like fibrillar assemblies in vitro. Such assemblies hold broad appeal in nanobiotechnology due to their ordered structure and to their ability to be functionalized. The catechol functional group, present in the non-coded L-3,4-dihydroxyphenylalanine (DOPA) amino acid, can take part in diverse chemical interactions. Moreover, DOPA-incorporated polymers have demonstrated adhesive properties and redox activity.
    [Show full text]